Abstract |
Pseudoakathisia (PsA) is characterised by the typical motor features of akathisia but there is a lack of subjective awareness. A total of 153 in-patients on neuroleptic medication hospitalized in two representative wards of the Psychiatric Hospital of Attica in Athens were rated on the census date using the Rating Scale for Drug-Induced Akathisia [Barnes, Br. J. Psychiatry, 154 (1989) 672-676], the Rating Scale for Extrapyramidal Side-Effects [Simpson and Angus, Acta Psychiatr. Scand. 212 (Suppl.) (1970) 11-19] and the Abnormal Involuntary Movements Scale [US Department of Health, Education and Welfare, ECDEU Assessment Manual (1976) pp. 534-537]. Eight subjects of the total in-patient population were found to have PsA of chronic type (point prevalence 5.23%). The point-prevalence of PsA among schizophrenic patients was 4.76%. In addition to the diagnosis of chronic pseudoakathisia, five patients (62.5%) had a concurrent diagnosis of chronic parkinsonism. Among patients with PsA, significant correlations were found between parkinsonism score and current daily dose of neuroleptics or high potency neuroleptics. There is evidence of a relationship between chronic pseudoakathisia, chronic parkinsonism and daily dose of neuroleptic.
|
Authors | B J Havaki-Kontaxaki, V P Kontaxakis, G N Christodoulou |
Journal | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
(Eur Neuropsychopharmacol)
Vol. 10
Issue 5
Pg. 333-6
(Sep 2000)
ISSN: 0924-977X [Print] Netherlands |
PMID | 10974603
(Publication Type: Journal Article)
|
Chemical References |
- Antiparkinson Agents
- Antipsychotic Agents
- Haloperidol
- Chlorpromazine
|
Topics |
- Adult
- Akathisia, Drug-Induced
(complications, epidemiology, physiopathology)
- Antiparkinson Agents
(adverse effects)
- Antipsychotic Agents
(adverse effects)
- Chlorpromazine
(adverse effects)
- Chronic Disease
- Female
- Greece
(epidemiology)
- Haloperidol
(adverse effects)
- Hospitals, Psychiatric
- Humans
- Inpatients
- Male
- Middle Aged
- Parkinson Disease
(complications)
- Prevalence
- Schizophrenia
(complications)
|